Mirvie
Pre-clinicalThe Mirvie RNA platform is first to predict unexpected complications before they happen by revealing the underlying biology of each pregnancy
Founded
2018
Focus
Diagnostics
About
The Mirvie RNA platform is first to predict unexpected complications before they happen by revealing the underlying biology of each pregnancy
Funding History
2Total raised: $135M
Series B$75MDecheng CapitalSep 15, 2022
Series A$60MKhosla VenturesDec 15, 2021
Company Info
TypePrivate
Founded2018
LocationSouth San Francisco, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile